A purine nucleoside analog called clofarabine is mostly used to treat acute lymphoblastic leukemia (ALL) in children. Its purpose is to obstruct DNA synthesis, which will stop cancer cells from proliferating. Under the brand name Clolar, clofarabine is a small but significant medicine in the oncology market that is mostly used to treat acute lymphoblastic leukemia (ALL) in children.
Clofarabine Market is expected to grow at a large rate, with a Compound Annual Growth Rate (CAGR) of remarkable growth from 2024 to 2034. The primary cause of this increase is the growing worldwide demand for clofarabine drugs, especially in hospital and pharmacy applications.
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation